Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ramos

Showing results (581-590 of 606) with videos related to

Pageof 61
Sort By:
Microbial Pathogenesis|October 11, 2019
Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humansThaís T O Santos, Mariana S Cardoso, Amanda S Machado, et al.
Viruses|September 28, 2023
B-Cell Epitopes-Based Chimeric Protein from SARS-CoV-2 N and S Proteins Is Recognized by Specific Antibodies in Serum and Urine Samples from PatientsFernanda F Ramos, Isabela A G Pereira, Mariana M Cardoso, et al.
Veterinary Parasitology|July 5, 2021
Serodiagnosis of canine leishmaniasis using a novel recombinant chimeric protein constructed with distinct B-cell epitopes from antigenic Leishmania infantum proteinsDanniele L Vale, Daniela P Lage, Amanda S Machado, et al.
Nature Microbiology|March 1, 2024
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host diseaseSarah Lindner, Oriana Miltiadous, Ruben J F Ramos, et al.
Cellular Immunology|November 13, 2017
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasisDaniel S Dias, Patrícia A F Ribeiro, Vívian T Martins, et al.
Cytokine|February 17, 2020
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasisPatrícia A F Ribeiro, Danniele L Vale, Daniel S Dias, et al.
Parasite (Paris, France)|April 14, 2021
In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasisCamila S Freitas, Daniela P Lage, João A Oliveira-da-Silva, et al.
Acta Tropica|December 25, 2019
A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasisAmanda S Machado, Fernanda F Ramos, João A Oliveira-da-Silva, et al.
Clinical Nutrition (Edinburgh, Scotland)|November 16, 2020
Myokines in treatment-naïve patients with cancer-associated cachexiaGabriela S de Castro, Joanna Correia-Lima, Estefania Simoes, et al.
Immunology Letters|January 26, 2020
Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
Pageof 61

Showing results (581-590 of 606) with videos related to

Sort By:
Pageof 61
Microbial Pathogenesis|October 11, 2019
Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humansThaís T O Santos, Mariana S Cardoso, Amanda S Machado, et al.
Viruses|September 28, 2023
B-Cell Epitopes-Based Chimeric Protein from SARS-CoV-2 N and S Proteins Is Recognized by Specific Antibodies in Serum and Urine Samples from PatientsFernanda F Ramos, Isabela A G Pereira, Mariana M Cardoso, et al.
Veterinary Parasitology|July 5, 2021
Serodiagnosis of canine leishmaniasis using a novel recombinant chimeric protein constructed with distinct B-cell epitopes from antigenic Leishmania infantum proteinsDanniele L Vale, Daniela P Lage, Amanda S Machado, et al.
Nature Microbiology|March 1, 2024
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host diseaseSarah Lindner, Oriana Miltiadous, Ruben J F Ramos, et al.
Cellular Immunology|November 13, 2017
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasisDaniel S Dias, Patrícia A F Ribeiro, Vívian T Martins, et al.
Cytokine|February 17, 2020
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasisPatrícia A F Ribeiro, Danniele L Vale, Daniel S Dias, et al.
Parasite (Paris, France)|April 14, 2021
In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasisCamila S Freitas, Daniela P Lage, João A Oliveira-da-Silva, et al.
Acta Tropica|December 25, 2019
A Leishmania infantum hypothetical protein evaluated as a recombinant protein and specific B-cell epitope for the serodiagnosis and prognosis of visceral leishmaniasisAmanda S Machado, Fernanda F Ramos, João A Oliveira-da-Silva, et al.
Clinical Nutrition (Edinburgh, Scotland)|November 16, 2020
Myokines in treatment-naïve patients with cancer-associated cachexiaGabriela S de Castro, Joanna Correia-Lima, Estefania Simoes, et al.
Immunology Letters|January 26, 2020
Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
Pageof 61